NEWS

May 2013 Membrane Technology5

I n B r i e f

Aquatech opens water treatment facility for producers of shale gas In the USA, Aquatech International Corp, which specialises in water purification technol-ogy for industrial and infrastructure markets, has formally opened its central water treatment

is committed to delivering added value to our customers through innovative technology devel-oped by using our vast experience and ongoing research and development in water treatment technologies. Our Tioga facility clearly demon-strates this commitment by bringing to regional shale gas operators a comprehensive portfolio of services for their water treatment needs.’

Inge hires representative for Spain With the aim of strengthening its position in the Spanish water industry, and furthering its own rapid growth in the ultrafiltration seg-

Water Solutions business, has hired Javier Uribe as its dedicated sales manager for Spain and Portugal. Uribe has been working for Inge as a distributor for the past four years. He holds a degree in business administration and economics, and has built his career around the sale and marketing of capital equipment.

LiqTech names Finn Helmer as its CEOFinn Helmer was recently appointed Chief Executive Officer, LiqTech International Inc – a cleantech company based in Ballerup,

-ogy based on silicon carbide (SiC) membranes. Commenting on this appointment, Aldo Petersen, Chairman, LiqTech, said: ‘Over the course of more than 40 years Finn has in many different situations successfully demonstrated his talent for leading and growing companies into meaningfully larger and more profitable companies.’ Petersen says that Finn’s ability to grow small technologically advanced compa-nies is going to be invaluable to LiqTech, par-ticularly as its enters into an important period for its SiC membrane technology.

Mar Cor acquires haemodialysis water business from SiemensThrough its subsidiary Mar Cor Purification Inc, US-based Cantel Medical Corp has continued the expansion of its water puri-fication and filtration segment by acquir-ing the haemodialysis water business from Siemens’ Water Technologies business unit. With approximately 600 dialysis customers in the USA and Canada, and 2012 revenue of approximately $9 million, this acquisition significantly expands Mar Cor Purification’s footprint in North America.

Bacteria from a measured sample volume of water are concentrated by a membrane filter. A fluorescent labelled enzyme substrate is added and the filter unit is incubated for 10–30 minutes, allowing bacterial enzymes to react with the substrate to form a fluorescent product. The number of bacteria is estimated by measuring the amount of fluorescence using a hand-held fluorometer. The signal produced is directly proportional to the amount of bacteria present.

Scientific studies have documented good correlations between Bactiquant-water and conventional plate counts and microscopic methods, says Elga.

The Bactiquant-water package includes sampling equipment, and the membrane filter, enzyme substrate and fluorometer. It also comes

-ible), which establishes a baseline for normal operation and, using statistical process-control based on ISO 11462-1, generates ‘‘normal’’, ‘‘alarm’’ and ‘‘action level’’ signals.

Contact:

Elga Process Water, Marlow International,

Park Way, Marlow, Buckinghamshire SL7 1YL, UK.

Tel: +44 1628 89 7000, www.elgaprocesswater.co.uk

Flowserve receives multi-million dollar order for ERDs and pumps from Cyprus

Flowserve Corp, a major provider of flow-control products and services

to the global infrastructure markets, has received a multi-million dollar order from M.N. Larnaca Desalination to supply pumps and energy-recovery devices (ERDs) for use in a sea-water reverse osmosis (SWRO) desalination plant located in the city of Larnaca on the southern coast of Cyprus.

-

Enterprise Ltd and Netcom Ltd, Cyprus, will design and rebuild the existing SWRO desali-nation plant and then operate the upgraded facility – which will be capable of producing 60 000 m3(15.9 million gallons) of water per day – for the next 25 years.

Booked during the first quarter of 2013,

pumps in the high-pressure feed service. Through its Calder brand of products and

technologies the company specialises in the design, engineering and supply of energy recovery equipment and related proprietary technologies for reverse osmosis used in desali-nation plants around the world.

which are isobaric machines, can recover as much as 97% of the hydraulic energy remain-ing in the brine stream – helping customers to significantly lower the cost of operating their facilities.

specifically designed for the desalination mar-ket, and enabled the company to work closely with M.N. Larnaca from the outset – helping it to identify and configure the most suitable, effi-cient and economical equipment for its plant.

Contact:

Flowserve Corp, 5215 North O’Connor Boulevard,

Suite 2300, Irving, TX 75039, USA.

Tel: +1 972 443 6500,

www.flowserve.com/Products/Energy-Recovery-Devices

Syringe filter is designed for small sample analysis using LCMS

US-based filtration, separation and purification company Pall Corp

recently introduced a syringe filter that is certified for low extractables in high-performance liquid chromatography/mass spectrometry (LCMS) applications.

The new 13-mm Acrodisc MS, which is designed specifically for small sample analysis using LCMS, complements the firm’s 25-mm Acrodisc MS syringe filter. According to Pall, it improves the accuracy of testing, enhances LCMS performance and extends the longevity of testing instrumentation.

Incorporating a water wettable polyte-trafluoroethylene (WWPTFE) membrane in a high-density polyethylene housing, the Acrodisc MS syringe filter can be used with both organic and aqueous solvents. It offers excellent chemical resistance and good particu-late retention with minimal protein adsorp-tion. This protects instrument columns from particulate build-up and reduces the frequency and cost of replacement.

The low extractable levels of this latest Acrodisc MS syringe filter minimise interfer-ence with the ionisation process and reduce the need for re-testing. This lowers costs while minimising down time caused by unexpected contamination.